{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:45:21Z","timestamp":1759938321457},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T00:00:00Z","timestamp":1385078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T00:00:00Z","timestamp":1385078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11095-013-1228-8","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T22:18:35Z","timestamp":1385072315000},"page":"1071-1081","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Transdermal Delivery and Cutaneous Targeting of Antivirals using a Penetration Enhancer and Lysolipid Prodrugs"],"prefix":"10.1007","volume":"31","author":[{"given":"Denisa","family":"Dibl\u00edkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kope\u010dn\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora","family":"\u0160kolov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Kre\u010dmerov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr","family":"Hrab\u00e1lek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate\u0159ina","family":"V\u00e1vrov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,22]]},"reference":[{"key":"1228_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261\u20138.","journal-title":"Nat Biotechnol"},{"key":"1228_CR2","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1073\/pnas.0501176102","volume":"102","author":"P Karande","year":"2005","unstructured":"Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A. 2005;102:4688\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1228_CR3","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.2174\/0929867054864822","volume":"12","author":"K Vavrova","year":"2005","unstructured":"Vavrova K, Zbytovska J, Hrabalek A. Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr Med Chem. 2005;12:2273\u201391.","journal-title":"Curr Med Chem"},{"key":"1228_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","volume":"56","author":"AC Williams","year":"2004","unstructured":"Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603\u201318.","journal-title":"Adv Drug Deliv Rev"},{"key":"1228_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","volume":"14","author":"BW Barry","year":"2001","unstructured":"Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001;14:101\u201314.","journal-title":"Eur J Pharm Sci"},{"key":"1228_CR6","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s11095-006-9108-0","volume":"23","author":"KB Sloan","year":"2006","unstructured":"Sloan KB, Wasdo SC, Rautio J. Design for optimized topical delivery: prodrugs and a paradigm change. Pharm Res. 2006;23:2729\u201347.","journal-title":"Pharm Res"},{"key":"1228_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd1877","volume":"4","author":"E De Clercq","year":"2005","unstructured":"De Clercq E, Holy A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov. 2005;4:928\u201340.","journal-title":"Nat Rev Drug Discov"},{"key":"1228_CR8","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.2174\/1381612033453668","volume":"9","author":"A Holy","year":"2003","unstructured":"Holy A. Phosphonomethoxyalkyl analogs of nucleotides. Curr Pharm Des. 2003;9:2567\u201392.","journal-title":"Curr Pharm Des"},{"key":"1228_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bcp.2011.03.027","volume":"82","author":"E De Clercq","year":"2011","unstructured":"De Clercq E. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond. Biochem Pharmacol. 2011;82:99\u2013109.","journal-title":"Biochem Pharmacol"},{"key":"1228_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.antiviral.2011.08.015","volume":"92","author":"AS Ray","year":"2011","unstructured":"Ray AS, Hostetler KY. Application of kinase bypass strategies to nucleoside antivirals. Antiviral Res. 2011;92:277\u201391.","journal-title":"Antiviral Res"},{"key":"1228_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3851\/IMP2012","volume":"22","author":"F Pertusati","year":"2011","unstructured":"Pertusati F, Serpi M, McGuigan C. Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy. Antivir Chem Chemother. 2011;22:181\u2013203.","journal-title":"Antivir Chem Chemother"},{"key":"1228_CR12","doi-asserted-by":"publisher","first-page":"A84","DOI":"10.1016\/j.antiviral.2009.01.005","volume":"82","author":"KY Hostetler","year":"2009","unstructured":"Hostetler KY. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. Antiviral Res. 2009;82:A84\u201398.","journal-title":"Antiviral Res"},{"key":"1228_CR13","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1007\/s11095-011-0508-4","volume":"28","author":"K Vavrova","year":"2011","unstructured":"Vavrova K, Kovarikova P, Skolova B, Libalova M, Roh J, Cap R. Enhanced topical and transdermal delivery of antineoplastic and antiviral acyclic nucleoside phosphonate cPr-PMEDAP. Pharm Res. 2011;28:3105\u201315.","journal-title":"Pharm Res"},{"key":"1228_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ejpb.2008.07.002","volume":"70","author":"K Vavrova","year":"2008","unstructured":"Vavrova K, Lorencova K, Novotny J, Holy A, Hrabalek A. Permeation enhancer dodecyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: influence of pH, ion-pairing and skin species. Eur J Pharm Biopharm. 2008;70:901\u20137.","journal-title":"Eur J Pharm Biopharm"},{"key":"1228_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejpb.2007.12.005","volume":"69","author":"K Vavrova","year":"2008","unstructured":"Vavrova K, Lorencova K, Klimentova J, Novotny J, Holy AN, Hrabalek A. Transdermal and dermal delivery of adefovir: effects of pH and permeation enhancers. Eur J Pharm Biopharm. 2008;69:597\u2013604.","journal-title":"Eur J Pharm Biopharm"},{"key":"1228_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s11095-008-9780-3","volume":"26","author":"J Novotny","year":"2009","unstructured":"Novotny J, Kovarikova P, Novotny M, Janusova B, Hrabalek A, Vavrova K. Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination. Pharm Res. 2009;26:811\u201321.","journal-title":"Pharm Res"},{"key":"1228_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2012.11.003","volume":"165","author":"B Janusova","year":"2013","unstructured":"Janusova B, Skolova B, Tukorova K, Wojnarova L, Simunek T, Mladenka P, et al. Amino acid derivatives as transdermal permeation enhancers. J Control Release. 2013;165:91\u2013100.","journal-title":"J Control Release"},{"key":"1228_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/bbrc.1996.0234","volume":"219","author":"J Balzarini","year":"1996","unstructured":"Balzarini J, Aquaro S, Perno CF, Witvrouw M, Holy A, De Clercq E. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Biochem Biophys Res Commun. 1996;219:337\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"1228_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1128\/AAC.37.2.332","volume":"37","author":"J Balzarini","year":"1993","unstructured":"Balzarini J, Holy A, Jindrich J, Naesens L, Snoeck R, Schols D, et al. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob Agents Chemother. 1993;37:332\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1228_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0166-3542(95)00058-5","volume":"28","author":"D Reymen","year":"1995","unstructured":"Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H, De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res. 1995;28:343\u201357.","journal-title":"Antiviral Res"},{"key":"1228_CR21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1128\/AAC.39.3.746","volume":"39","author":"TW Vahlenkamp","year":"1995","unstructured":"Vahlenkamp TW, De Ronde A, Balzarini J, Naesens L, De Clercq E, van Eijk MJ, et al. (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection. Antimicrob Agents Chemother. 1995;39:746\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1228_CR22","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.bmc.2012.12.044","volume":"21","author":"M Krecmerova","year":"2013","unstructured":"Krecmerova M, Jansa P, Dracinsky M, Sazelova P, Kasicka V, Neyts J, et al. 9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: Optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro. Bioorg Med Chem. 2013;21:1199\u2013208.","journal-title":"Bioorg Med Chem"},{"key":"1228_CR23","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1021\/jm901828c","volume":"53","author":"M Krecmerova","year":"2010","unstructured":"Krecmerova M, Holy A, Andrei G, Pomeisl K, Tichy T, Brehova P, et al. Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents. J Med Chem. 2010;53:6825\u201337.","journal-title":"J Med Chem"},{"key":"1228_CR24","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1128\/AAC.35.11.2440","volume":"35","author":"JC Lin","year":"1991","unstructured":"Lin JC, De Clercq E, Pagano JS. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication. Antimicrob Agents Chemother. 1991;35:2440\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"1228_CR25","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1128\/AAC.33.9.1482","volume":"33","author":"MS Smith","year":"1989","unstructured":"Smith MS, Brian EL, De Clercq E, Pagano JS. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3\u2032-azido-3\u2032-deoxythymidine. Antimicrob Agents Chemother. 1989;33:1482\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1228_CR26","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1021\/jm960314q","volume":"39","author":"A Holy","year":"1996","unstructured":"Holy A, Dvorakova H, Jindrich J, Masojidkova M, Budesinsky M, Balzarini J, et al. Acyclic nucleotide analogs derived from 8-azapurines: synthesis and antiviral activity. J Med Chem. 1996;39:4073\u201388.","journal-title":"J Med Chem"},{"key":"1228_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.antiviral.2009.09.012","volume":"84","author":"N Valiaeva","year":"2009","unstructured":"Valiaeva N, Prichard MN, Buller RM, Beadle JR, Hartline CB, Keith KA, et al. Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses. Antiviral Res. 2009;84:254\u20139.","journal-title":"Antiviral Res"},{"key":"1228_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jchromb.2007.03.012","volume":"853","author":"K Vavrova","year":"2007","unstructured":"Vavrova K, Lorencova K, Klimentova J, Novotny J, Hrabalek A. HPLC method for determination of in vitro delivery through and into porcine skin of adefovir (PMEA). J Chromatogr B Analyt Technol Biomed Life Sci. 2007;853:198\u2013203.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1228_CR29","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1016\/j.bmc.2006.08.014","volume":"14","author":"T Holas","year":"2006","unstructured":"Holas T, Vavrova K, Sima M, Klimentova J, Hrabalek A. Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of Transkarbam 12. Bioorg Med Chem. 2006;14:7671\u201380.","journal-title":"Bioorg Med Chem"},{"key":"1228_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2010.11.017","volume":"150","author":"M Novotny","year":"2011","unstructured":"Novotny M, Klimentova J, Janusova B, Palat K, Hrabalek A, Vavrova K. Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action. J Control Release. 2011;150:164\u201370.","journal-title":"J Control Release"},{"key":"1228_CR31","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.1016\/j.bmc.2006.08.013","volume":"14","author":"J Klimentova","year":"2006","unstructured":"Klimentova J, Kosak P, Vavrova K, Holas T, Hrabalek A. Influence of terminal branching on the transdermal permeation-enhancing activity in fatty alcohols and acids. Bioorg Med Chem. 2006;14:7681\u20137.","journal-title":"Bioorg Med Chem"},{"key":"1228_CR32","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/COH.0b013e3283582ca7","volume":"7","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Szpir M. Current status of topical antiretroviral chemoprophylaxis. Curr Opin HIV AIDS. 2012;7:520\u20135.","journal-title":"Curr Opin HIV AIDS"},{"key":"1228_CR33","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1128\/AAC.49.12.4843-4852.2005","volume":"49","author":"F Dal Pozzo","year":"2005","unstructured":"Dal Pozzo F, Andrei G, Holy A, Van Den Oord J, Scagliarini A, De Clercq E, et al. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures. Antimicrob Agents Chemother. 2005;49:4843\u201352.","journal-title":"Antimicrob Agents Chemother"},{"key":"1228_CR34","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1128\/AAC.00838-07","volume":"51","author":"S Duraffour","year":"2007","unstructured":"Duraffour S, Snoeck R, Krecmerova M, van Den Oord J, De Vos R, Holy A, et al. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models. Antimicrob Agents Chemother. 2007;51:4410\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1228_CR35","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1128\/AAC.46.11.3356-3361.2002","volume":"46","author":"R Snoeck","year":"2002","unstructured":"Snoeck R, Holy A, Dewolf-Peeters C, Van Den Oord J, De Clercq E, Andrei G. Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures. Antimicrob Agents Chemother. 2002;46:3356\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"1228_CR36","first-page":"1","volume":"52","author":"J Cono","year":"2003","unstructured":"Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recomm Rep. 2003;52:1\u201328.","journal-title":"MMWR Recomm Rep"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-1228-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-013-1228-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-1228-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-1228-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:14:19Z","timestamp":1684865659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-013-1228-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,22]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1007\/s11095-013-1228-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,22]]},"assertion":[{"value":"7 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}